Besides the broad development of nanotechnological approaches for cancer diagnosis and
therapy, currently, there is no significant progress in the treatment of different types of brain …

Nanotechnology is a fast-evolving field focused on fabricating nanoscale objects for
industrial, cosmetic, and therapeutic applications. Virus-like particles (VLPs) are self …

Viral infectious diseases threaten human health and global stability. Several vaccine
platforms, such as DNA, mRNA, recombinant viral vectors, and virus-like particle-based …

Virus-like particles (VLPs) are nanostructures assemble from viral proteins. Besides widely
used for vaccine development, VLPs have also been explored as nanocarriers for cargo …

Abstract Epstein-Barr virus (EBV), a γ-herpesvirus, is the first identified oncogenic virus,
which establishes permanent infection in humans. EBV causes infectious mononucleosis …

RNAi technology is a versatile, effective, safe, and eco-friendly alternative for crop
protection. There is plenty of evidence of its use through host-induced gene silencing (HIGS) …

Viral nanoparticles (VNPs) are self-assembling, adaptable delivery systems for vaccines and
other therapeutic agents used in a variety of biomedical applications. The potential of …

Virus-like particles (VLPs) are empty, nanoscale structures morphologically resembling
viruses. Internal cavity, noninfectious, and particulate nature with a high density of repeating …

Viruses and the recombinant protein cages assembled from their structural proteins, known
as virus‐like particles (VLPs), have gained wide interest as tools in biotechnology and …

Hemorrhagic septicemia (HS) caused by Pasteurella multocida B: 2 and E: 2 is among the
fatal bacterial diseases in cattle and buffaloes that are economically valuable in Asian and …